CSL Behring (Portugal)
CSL Behring (Portugal) is the Portuguese entity of CSL Behring, a global biotherapeutics business of CSL.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
CSL Behring (Portugal) is a company in Lisbon, Portugal, and forms part of CSL Behring, a global biotherapeutics leader driven by its promise to save lives. CSL Behring discovers, develops and delivers innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas, using three strategic scientific platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy. Its parent company, CSL, is headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
History
CSL Behring (Portugal) is a company in Lisbon, Portugal. It is part of CSL Behring, a global biotherapeutics leader driven by its promise to save lives, which discovers, develops and delivers innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. CSL Behring uses three strategic scientific platforms — plasma fractionation, recombinant protein technology, and cell and gene therapy — to support continued innovation. Its parent company, CSL, is headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
Products and positioning
Global biotherapeutics leader driven by the promise to save lives.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/csl-behring-portugal · Editorial policy · How profiles are compiled